Beta Bionics, Inc. (BBNX) Current Ratio
- Current ratio · latest quarter: Value 8.88×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 8.88× | Current assets / current liabilities. $231.03M ÷ $26.02M ≈ 8.88× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 231.03M USD | Assets, Current |
| Current obligations | 26.02M USD | Liabilities, Current |
| Cash and equivalents | 44.32M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 18.05M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 23.92M USD | Inventory, Net |
| Payables | 5.35M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $231.03M | $26.02M | $44.32M | (m) | $18.05M | $23.92M | $5.35M | (m) | 8.88× |
| 2026-03-31 | $247.99M | $23.19M | $30.21M | (m) | $15.75M | $23.73M | $2.32M | (m) | 10.69× |
| 2025-12-31 | $267.90M | $30.92M | $31.58M | (m) | $17.12M | $21.72M | $5.00M | (m) | 8.66× |
| 2025-09-30 | $270.03M | $25.39M | $38.48M | (m) | $11.54M | $20.37M | $4.46M | (m) | 10.64× |
| 2025-06-30 | $286.07M | $19.49M | $35.08M | (m) | $11.39M | $17.32M | $3.42M | (m) | 14.68× |
| 2025-03-31 | $261.92M | $16.49M | $42.45M | (m) | $9.06M | $15.73M | $3.45M | (m) | 15.88× |
| 2024-12-31 | $132.92M | $21.15M | $30.43M | (m) | $12.00M | $13.32M | $2.85M | (m) | 6.29× |
| 2023-12-31 | $103.62M | $10.61M | $26.57M | (m) | $4.45M | $1.25M | $1.17M | (m) | 9.77× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |